Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases
Abstract: The cholinergic system plays an essential role in brain development, physiology, and pathophysiology. Herein, we review how specific alterations in this system, through genetic mutations or abnormal receptor function, can lead to aberrant neural circuitry that triggers disease. The review...
Guardado en:
Autores principales: | , |
---|---|
Formato: | Artículo |
Lenguaje: | Inglés |
Publicado: |
Multidisciplinary Digital Publishing Institute
2023
|
Materias: | |
Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/16987 |
Aporte de: |
id |
I33-R139-123456789-16987 |
---|---|
record_format |
dspace |
spelling |
I33-R139-123456789-169872023-08-26T05:04:26Z Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases Vallés, Ana Sofía Barrantes, Francisco José ENFERMEDAD DE ALZHEIMER ENFERMEDAD DE PARKINSON EPILEPSIA ESPECTRO DE ESQUIZOFRENIA ADICCIONES SALUD ENFERMEDADES Abstract: The cholinergic system plays an essential role in brain development, physiology, and pathophysiology. Herein, we review how specific alterations in this system, through genetic mutations or abnormal receptor function, can lead to aberrant neural circuitry that triggers disease. The review focuses on the nicotinic acetylcholine receptor (nAChR) and its role in addiction and in neurodegenerative and neuropsychiatric diseases and epilepsy. Cholinergic dysfunction is associated with inflammatory processes mainly through the involvement of α7 nAChRs expressed in brain and in peripheral immune cells. Evidence suggests that these neuroinflammatory processes trigger and aggravate pathological states. We discuss the preclinical evidence demonstrating the therapeutic potential of nAChR ligands in Alzheimer disease, Parkinson disease, schizophrenia spectrum disorders, and in autosomal dominant sleep-related hypermotor epilepsy. PubMed and Google Scholar bibliographic databases were searched with the keywords indicated below. 2023-08-25T13:15:27Z 2023-08-25T13:15:27Z 2023 Artículo Vallés, A. S., Barrantes, F. J. Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases [en línea]. Cells. 2023, 12(16). doi:10.3390/cells12162051. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/16987 2073-4409 (online) https://repositorio.uca.edu.ar/handle/123456789/16987 10.3390/cells12162051 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Cells.Vol.12, No.16, 2023 |
institution |
Universidad Católica Argentina |
institution_str |
I-33 |
repository_str |
R-139 |
collection |
Repositorio Institucional de la Universidad Católica Argentina (UCA) |
language |
Inglés |
topic |
ENFERMEDAD DE ALZHEIMER ENFERMEDAD DE PARKINSON EPILEPSIA ESPECTRO DE ESQUIZOFRENIA ADICCIONES SALUD ENFERMEDADES |
spellingShingle |
ENFERMEDAD DE ALZHEIMER ENFERMEDAD DE PARKINSON EPILEPSIA ESPECTRO DE ESQUIZOFRENIA ADICCIONES SALUD ENFERMEDADES Vallés, Ana Sofía Barrantes, Francisco José Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
topic_facet |
ENFERMEDAD DE ALZHEIMER ENFERMEDAD DE PARKINSON EPILEPSIA ESPECTRO DE ESQUIZOFRENIA ADICCIONES SALUD ENFERMEDADES |
description |
Abstract:
The cholinergic system plays an essential role in brain development, physiology, and pathophysiology. Herein, we review how specific alterations in this system, through genetic mutations or abnormal receptor function, can lead to aberrant neural circuitry that triggers disease. The review focuses on the nicotinic acetylcholine receptor (nAChR) and its role in addiction and in neurodegenerative and neuropsychiatric diseases and epilepsy. Cholinergic dysfunction is associated with inflammatory processes mainly through the involvement of α7 nAChRs expressed in brain and in peripheral immune cells. Evidence suggests that these neuroinflammatory processes trigger and aggravate pathological states. We discuss the preclinical evidence demonstrating the therapeutic potential of nAChR ligands in Alzheimer disease, Parkinson disease, schizophrenia spectrum disorders, and in autosomal dominant sleep-related hypermotor epilepsy. PubMed and Google Scholar bibliographic databases were searched with the keywords indicated below. |
format |
Artículo |
author |
Vallés, Ana Sofía Barrantes, Francisco José |
author_facet |
Vallés, Ana Sofía Barrantes, Francisco José |
author_sort |
Vallés, Ana Sofía |
title |
Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
title_short |
Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
title_full |
Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
title_fullStr |
Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
title_full_unstemmed |
Nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
title_sort |
nicotinic acetylcholine receptor dysfunction in addiction and in some neurodegenerative and neuropsychiatric diseases |
publisher |
Multidisciplinary Digital Publishing Institute |
publishDate |
2023 |
url |
https://repositorio.uca.edu.ar/handle/123456789/16987 |
work_keys_str_mv |
AT vallesanasofia nicotinicacetylcholinereceptordysfunctioninaddictionandinsomeneurodegenerativeandneuropsychiatricdiseases AT barrantesfranciscojose nicotinicacetylcholinereceptordysfunctioninaddictionandinsomeneurodegenerativeandneuropsychiatricdiseases |
_version_ |
1807949252166418432 |